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Diagnostic exome sequencing을 통한 KBG 증후군의 조기 진단
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Early Diagnosis of KBG Syndrome Using Diagnostic 
Exome Sequencing
KBG syndrome is a rare neurodevelopmental disorder characterized by intellectual 
disability, skeletal anomalies, short stature, craniofacial dysmorphism, and 
macrodontia. ANKRD11 gene mutation and 16q24.3 microdeletion have been 
reported to cause KBG syndrome. Here, we report two patients with ANKRD11 
mutations who initially presented with neurologic symptoms such as developmental 
delay and seizures. Patient 1 was a 23-month-old boy who presented with a 
global developmental delay. Language delay was the most dominant feature. He 
had hypertelorism, hearing impairment, and behavior problems characterized as 
hyperactivity. A c.1903_1907delAAACA (p.Lys635GInfsTer26) mutation in ANKRD11 
was identified with diagnostic exome sequencing. Patient 2 was a 14-month-
old boy with developmental delay and seizure. He also had atrial septum defect, 
and ventricular septal defect. Generalized tonic seizures began at the age of 
8 months. Electroencephalography showed generalized sharp and slow wave 
pattern. Seizures did not respond to antiepileptic drugs. A loss of function mutation 
c.5350_5351delTC (p.ser1784HisfsTer12) in ANKRD11 was identified with diagnostic 
exome sequencing. In both cases, characteristic features of KBG syndrome such 
as short stature or macrodontia, were absent, and they visited the hospital due 
to neurological symptoms. These findings suggest that more patients with mild 
phenotypes of KBG syndrome are being recognized with advances in diagnostic 
exome sequencing genetic technologies. 
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Introduction
KBG syndrome (OMIM 148050) is a rare neurodevelopmental disorder, that 
typically presents with characteristic dysmorphisms1). Clinical characteristics 
include distinctive craniofacial findings and skeletal anomalies2). Previous studies 
have recommended diagnostic criteria of KBG syndrome focusing on these 
morphological abnormalities3,4). A patient can be diagnosed with KBG syndrome 
if they meet 4 or more of the following 8 major criteria: macrodontia of the upper 
central incisors, characteristic facial appearance, hand anomalies, neurological 
involvement, delayed bone age (2 standard deviations below the mean), 
costovertebral anomalies, postnatal short stature, and presence of a first-degree 
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relative with KBG syndrome4). The causative gene, ANKRD11, 
was discovered through whole-exome sequencing in 20115). 
More diverse phenotypes are being reported in patients with 
ANKRD11 gene mutations and KBG syndrome. It is estimated 
that KBG syndrome is under-diagnosed and that recent 
advances in massive parallel sequencing will increase early 
detection of the milder forms of KBG syndrome. 
Here, we report two patients who had milder or atypical 
forms of KBG syndrome. Both were diagnosed with diagnostic 
exome sequencing when they were younger than 24 months.  
Case Reports
1. Patient 1
A 23-month-old boy was referred to our hospital because of 
developmental delay. He was born at 38 weeks of gestation by 
cesarean section and his birth weight was 2,700 g (10–25th 
percentile). He was an only child of non-consanguineous, 
average intelligence Korean parents. His mother was 40 years 
old and his father was 38 years old at his conception. 
The patient showed developmental delay from his early life. 
He could not control his head until he was 5 months old and he 
could not sit when he was 9 months old. When he visited the 
clinic at the age of 23 months, he could only stand with 
assistance, not by himself. He could not yet speak his first word 
at the age of 23 months.  
On physical examination, his height (87 cm, 50–75th 
percentile) and head circumference (49 cm, 50–75th percentile) 
were measured to be adequate for his age. He had dysmorphic 
features such as a prominent forehead, prominent ears, and 
hypertelorism, but no macrodontia. He had no skeletal abnor-
malities nor hand abnormalities (Fig. 1). He had mild hearing 
impairment, but no other congenital anomalies.
Brain magnetic resonance imaging (MRI) did not reveal any 
abnormal findings (Fig. 1). Chromosomal microarray and 
multiplex ligation dependent probe amplification (MLPA) test for 
Miller-Dieker syndrome (17p), Prader-Willi/Angelman 
syndrome, DiGeorge syndrome(22q11), Williams syndrome 
were negative. Diagnostic exome sequencing was performed 
and a likely pathogenic mutation c.1903_1907delAAACA 
(p.Lys635GInfsTer26) causing loss of function in the ANKRD11 
gene was identified.  
During his follow-up visits, he began to speak. At the age of 
30 months, he spoke his first word, and at the age of 40 months, 
he spoke his first sentence. The Bayley Scales of Infant 
Development test conducted at 31 months showed his mental 
developmental index to be 52, and psychomotor developmental 
index to be below 50. At the age of 50 months, his height was 
104.4 cm, 50–75th percentile. 
2. Patient 2
A 14-month-old boy was referred to our hospital because of 
developmental delay and epilepsy. He was born at 39 weeks of 
gestation following a normal pregnancy and birth weight was 
4,160 g (>90th percentile). 
He showed global developmental delay and clinical seizures 
from his early life. His motor development was significantly 
delayed, and he could sit only with assistance. His eye contact 
and social smiling was also poor. On physical examination, he 
had dysmorphisms, such as a round head and round nose. His 
height was 80.5 cm (75th–90th percentile), weight was 10.3 kg 
(25th–50th percentile), and head circumference was 46.2 cm 
(25–50th percentile) at 14 months of age. He had an atrial septal 
defect and ventricular septal defect. 
He had several seizure attacks presenting as vacant staring 
and head falling, beginning at 7 months of age, and his seizures 
are not well controlled by multiple antiepileptic drugs. 
Electroencephalography showed inconsistent slowing, 
generalized polyspikes and generalized spikes and slow waves. 
His brain MRI was grossly normal (Fig. 2A).  
No abnormality was shown in a chromosome study and 
comparative genomic hybridization (CGH) array. A loss of 
function mutation c.5350_5351delTC (p.ser1784HisfsTer12) in 
ANKRD11 was detected when we performed diagnostic exome 
sequencing.
During his follow up visits, at the 28 months of age, he 
continued to have daily seizures despite the use of sodium 
valproate, topiramate, vigabatrin and clobazam. His electro-
encephalography (EEG) began to show frontally dominant slow-
(B) (A)  
Fig. 1. X-ray and brain magnetic resonance imaging (MRI) finding for 
Patient 1. (A) No skeletal abnormalities of chest cavity and spine. (B) Normal 
T2 weighted axial MRI at 11 months of age.
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spike wave discharges which were characteristics of Lennox-
Gastaut syndrome (Fig. 2B). He then began to develop 
myoclonic-tonic-clonic seizures. However, after he developed 
myoclonic-tonic-clonic seizures, a high dose prednisolone of 
40 mg was prescribed for 2 weeks, and he became seizure free 
for 1 month. His height was 94.2 cm (75–90th percentile) at the 
age of 28 months.
Discussion
ANKRD11 is a member of the ankyrin repeat-containing 
cofactors family. ANKRD11 interacts with p160 nuclear receptor 
co-activators and inhibits ligand-dependent transcriptional 
activation of target genes by nuclear receptors6). We reviewed 
two cases of KBG syndrome confirmed by ANKRD11 gene 
mutation.    
KBG syndrome affects various systems such as cardiology, 
otolaryngology, ophthalmology, dentistry, endocrinology, and 
neurology. The degree of disabilities and abnormalities differ 
among individuals. A previous study reported a wide range of 
neurodevelopment levels among patients with ANKRD11 muta-
tions7). Some patients had normal intellectual function, while 
others were unable to live without assistance8). Likewise, the two 
patients in our cases showed different levels of delayed 
development. The patient with more severe delayed develop-
ment had seizures and abnormal EEG findings. 
According to previous reports, seizures are present in 
approximately 28–30% of patients with KBG syndrome, and 
EEG abnormalities are reported in 50–100% of patients4,7). 
However, there are few reports of seizure types or EEG findings 
in patients with KBG syndrome. One of our patients had 
seizures, and the other patient had no seizures. The patient with 
seizures had myoclonic-tonic seizures and electroencephalo-
graphy showed inconsistent slowing, generalized polyspikes and 
generalized spike and slow waves. The development of this 
patient was more delayed, which may have been due to his 
seizures. This patient's seizures had not been well controlled. 
Despite treatment with multiple antiepileptic drugs (sodium 
valproate, topiramate, and clobazam), he had several episode of 
seizures almost daily. Based on previous studies that high dose 
prednisolone was helpful in seizure control in drug resistance 
epilepsy9,10), we performed a high dose prednisolone trial in this 
patient. After taking a high dose of prednisolone for 2 weeks, he 
became seizure free. Further investigation is needed to confirm 
whether these responses are persistent in patients with 
ANKRD11 mutation-positive KBG syndrome.
In our cases, characteristic abnormalities such as macrodontia 
or small height were absent. The main presenting symptoms 
were neurological symptoms, such as seizures and develop-
mental delay. Both could not be diagnosed as KBG syndrome 
according to the clinical diagnostic criteria because both had 
mild symptoms and were lacking the major characteristics of 
KBG syndrome. These two patients could be molecularly 
diagnosed because diagnostic exome sequencing identified 
ANKRD11 mutations.
We found two patients with ANKRD11 gene mutations who 
manifested with neurologic symptoms. With advances in genetic 
technologies, more patients who harbor ANKRD11 will be 
identified.
요약 
KBG 증후군은 특징적인 얼굴 기형 및 발달 장애, 저 신장 등을 보
이는 희귀한 질환이며, ANKRD11유전자의 변이가 KBG 증후군을 일
으킨다고 알려져 있다. 그 임상 양상의 스펙트럼은 넓은 편이며, 발달 
장애와 신경학적 이상의 경우 개인마다 다양한 정도로 보고되고 있
(A) (B)
Fig. 2. Brain MRI and electroencephalography finding for Patient 2. (A) Normal T2 weighted axial MRI at 8 
months of age. (B) EEG showing inconsistent slowing on both frontal areas and frequent generalized polyspikes.
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다. 본 증례의 환자들 역시 서로 다른 정도의 발달 장애를 보였으며, 
그 중 더 심한 정도의 발달 장애를 가진 환자에서는 뇌전증이 동반되
었다. 기존의 KBG증후군의 진단 기준에서 macrodontia는 매우 중요
한 요소였으며, 대부분의 KBG 증후군 환자에서 나타난다고 보고되
었다. 본 증례의 환자들은 발달장애를 보여 시행한 diagnostic 
exome sequencing을 통해 ANKRD11 유전자 이상을 확인하였지만 
macrodontia는 관찰되지 않았다. 이는 KBG 증후군이 현재까지 밝
혀진 것 보다 더 흔할 수 있으며, 특징적인 얼굴 기형이 없는 경우에도 
발달장애가 있는 환자들에서는 더욱 적극적인 유전자 검사를 시행하
여 KBG 증후군을 진단 할 필요가 있음을 시사한다. 
References 
 1) Herrmann J, Pallister PD, Tiddy W, Opitz JM. The KBG synd­
rome­a syndrome of short stature, characteristic facies, mental 
retardation, macrodontia and skeletal anomalies. Birth Defects 
Orig Artic Ser 1975;11:7­18.
 2) Brancati F, Sarkozy A, Dallapiccola B. KBG syndrome. Orphanet 
J Rare Dis 2006;1:50.
 3) Zollino M, Battaglia A, D'Avanzo MG, Della Bruna MM, Marini R, 
Scarano G, et al. Six additional cases of the KBG syndrome: 
clinical reports and outline of the diagnostic criteria. Am J Med 
Genet 1994;52:302­7.
 4) Skjei KL, Martin MM, Slavotinek AM. KBG syndrome: report of 
twins, neurological characteristics, and delineation of diagnostic 
criteria. Am J Med Genet A 2007;143A:292­300.
 5) Sirmaci A, Spiliopoulos M, Brancati F, Powell E, Duman D, 
Abrams A, et al. Mutations in ANKRD11 cause KBG syndrome, 
characterized by intellectual disability, skeletal malformations, 
and macrodontia. Am J Hum Genet 2011;89:289­94.
 6) Zhang A, Yeung PL, Li CW, Tsai SC, Dinh GK, Wu X, et al. 
Identification of a novel family of ankyrin repeats containing 
cofactors for p160 nuclear receptor coactivators. J Biol Chem 
2004;279:33799­805.
 7) Kim HJ, Cho E, Park JB, Im WY, Kim HJ. A Korean family with 
KBG syndrome identified by ANKRD11 mutation, and 
phenotypic comparison of ANKRD11 mutation and 16q24.3 
microdeletion. Eur J Med Genet 2015;58:86­94.
 8) Swols DM, Foster J, Tekin M. KBG syndrome. Orphanet J Rare 
Dis 2017;12:183. 
 9) You SJ, Jung DE, Kim HD, Lee HS, Kang HC. Efficacy and 
prognosis of a short course of prednisolone therapy for pediatric 
epilepsy. Eur J of Pediatr Neurol 2008;12:314­20.
10) Sinclair DB. Prednisone therapy in pediatric epilepsy. Pediatr 
Neurol 2003;28:194­98.
